Javascript must be enabled to continue!
Predictive model for aminoglycoside induced ototoxicity
View through CrossRef
BackgroundIrreversible hearing loss is a well-known adverse effect of aminoglycosides, however, inability to accurately predict ototoxicity is a major limitation in clinical care. We addressed this limitation by developing a prediction model for aminoglycoside ototoxicity applicable to the general population.MethodsWe employed a prospective non-drug-resistant tuberculosis (TB), non-HIV/AIDS cohort of 153 adults on Streptomycin based anti-TB therapy. High frequency pure-tone audiometry was done at regular intervals throughout the study. Clinical and audiological predictors of ototoxicity were collated and ototoxic threshold shift from the baseline audiogram computed. The prediction model was developed with logistic regression method by examining multiple predictors of ototoxicity. Series of models were fitted sequentially; the best model was identified using Akaike Information Criterion and likelihood ratio test. Key variables in the final model were used to develop a logit model for ototoxicity prediction.ResultsOtotoxicity occurred in 35% of participants. Age, gender, weight, cumulative Streptomycin dosage, social class, baseline pure tone average (PTA) and prior hearing symptoms were explored as predictors. Multiple logistic regression showed that models with age, cumulative dosage and baseline PTA were best for predicting ototoxicity. Regression parameters for ototoxicity prediction showed that yearly age increment raised ototoxicity risk by 5% (AOR = 1.05; CI, 1.01–1.09), and a gram increase in cumulative dosage increased ototoxicity risk by 7% (AOR = 1.05; CI, 1.05–1.12) while a unit change in baseline log (PTA) was associated 254% higher risk of ototoxicity (AOR = 3.54, CI: 1.25, 10.01). Training and validation models had area under the receiver operating characteristic curve as 0.84 (CI, 0.76–0.92) and 0.79 (CI, 0.62–0.96) respectively, showing the model has discriminatory ability.ConclusionThis model can predict aminoglycoside ototoxicity in the general population.
Title: Predictive model for aminoglycoside induced ototoxicity
Description:
BackgroundIrreversible hearing loss is a well-known adverse effect of aminoglycosides, however, inability to accurately predict ototoxicity is a major limitation in clinical care.
We addressed this limitation by developing a prediction model for aminoglycoside ototoxicity applicable to the general population.
MethodsWe employed a prospective non-drug-resistant tuberculosis (TB), non-HIV/AIDS cohort of 153 adults on Streptomycin based anti-TB therapy.
High frequency pure-tone audiometry was done at regular intervals throughout the study.
Clinical and audiological predictors of ototoxicity were collated and ototoxic threshold shift from the baseline audiogram computed.
The prediction model was developed with logistic regression method by examining multiple predictors of ototoxicity.
Series of models were fitted sequentially; the best model was identified using Akaike Information Criterion and likelihood ratio test.
Key variables in the final model were used to develop a logit model for ototoxicity prediction.
ResultsOtotoxicity occurred in 35% of participants.
Age, gender, weight, cumulative Streptomycin dosage, social class, baseline pure tone average (PTA) and prior hearing symptoms were explored as predictors.
Multiple logistic regression showed that models with age, cumulative dosage and baseline PTA were best for predicting ototoxicity.
Regression parameters for ototoxicity prediction showed that yearly age increment raised ototoxicity risk by 5% (AOR = 1.
05; CI, 1.
01–1.
09), and a gram increase in cumulative dosage increased ototoxicity risk by 7% (AOR = 1.
05; CI, 1.
05–1.
12) while a unit change in baseline log (PTA) was associated 254% higher risk of ototoxicity (AOR = 3.
54, CI: 1.
25, 10.
01).
Training and validation models had area under the receiver operating characteristic curve as 0.
84 (CI, 0.
76–0.
92) and 0.
79 (CI, 0.
62–0.
96) respectively, showing the model has discriminatory ability.
ConclusionThis model can predict aminoglycoside ototoxicity in the general population.
Related Results
Extended-Interval Aminoglycoside Administration for Children: A Meta-analysis
Extended-Interval Aminoglycoside Administration for Children: A Meta-analysis
Background. There has been a long-standing debate regarding whether aminoglycosides should be administered on a multiple daily dosing (MDD) or once-daily dosing (ODD) schedule. Sev...
ecision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predi
ecision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predi
The scope of sensor networks and the Internet of Things spanning rapidly to diversified domains but not limited to sports, health, and business trading. In recent past, the sensors...
Ototoxicity of Non-aminoglycoside Antibiotics
Ototoxicity of Non-aminoglycoside Antibiotics
It is well-known that aminoglycoside antibiotics can cause significant hearing loss and vestibular deficits that have been described in animal studies and in clinical reports. The ...
Mitochondrial mutations associated with aminoglycoside ototoxicity and hearing loss susceptibility identified by meta-analysis
Mitochondrial mutations associated with aminoglycoside ototoxicity and hearing loss susceptibility identified by meta-analysis
Background
Genetic variations, including mitochondrial mutations, are important contributors to hearing loss, especially in children, and newborn genetic screens ...
POTENTIAL OTOTOXIC EFFECTS
OF DIFFERENT GENERATIONS
OF EGFR TYROSINE KINASE INHIBITORS:
A LITERATURE REVIEW
POTENTIAL OTOTOXIC EFFECTS
OF DIFFERENT GENERATIONS
OF EGFR TYROSINE KINASE INHIBITORS:
A LITERATURE REVIEW
Relevance: Lung cancer is one of the most frequent malignant tumors, and non-small cell lung cancer (NSCLC) accounts for
approximately 85% of all cases. Mutations in the epidermal...
POTENTIAL OTOTOXIC EFFECTS
OF DIFFERENT GENERATIONS
OF EGFR TYROSINE KINASE INHIBITORS:
A LITERATURE REVIEW
POTENTIAL OTOTOXIC EFFECTS
OF DIFFERENT GENERATIONS
OF EGFR TYROSINE KINASE INHIBITORS:
A LITERATURE REVIEW
Relevance: Lung cancer is one of the most frequent malignant tumors, and non-small cell lung cancer (NSCLC) accounts for
approximately 85% of all cases. Mutations in the epidermal...
POTENTIAL OTOTOXIC EFFECTS
OF DIFFERENT GENERATIONS
OF EGFR TYROSINE KINASE INHIBITORS:
A LITERATURE REVIEW
POTENTIAL OTOTOXIC EFFECTS
OF DIFFERENT GENERATIONS
OF EGFR TYROSINE KINASE INHIBITORS:
A LITERATURE REVIEW
Relevance: Lung cancer is one of the most frequent malignant tumors, and non-small cell lung cancer (NSCLC) accounts for
approximately 85% of all cases. Mutations in the epidermal...
Detection of aac3IIc, aac(6)Ib and armA gene encoding aminoglycoside resistance in Klebsiella pneumoniae in Burkina Faso.
Detection of aac3IIc, aac(6)Ib and armA gene encoding aminoglycoside resistance in Klebsiella pneumoniae in Burkina Faso.
Background: Klebsiella pneumoniae is the second most frequently isolated bacterium in medical bacteriology laboratory after Escherichia coli. It can be responsible for many infecti...

